Medical Services (CE) (USOTC:MSITF)
Historical Stock Chart
From Aug 2019 to Aug 2024
![Click Here for more Medical Services (CE) Charts. Click Here for more Medical Services (CE) Charts.](/p.php?pid=staticchart&s=NO%5EMSITF&p=8&t=15)
EDMONTON, Alberta, July 5 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that interest in its West Nile rapid test kit is increasing. The season for mosquitoes that carry the West Nile is about to start and regulatory authorities in several countries have approached the Company through its distributors to get test data and samples. This year is expected to be an active year for mosquitoes carrying West Nile. This corresponds to the increase in VScan rapid test kits for Dengue Fever and Malaria.
All countries with hot climates that have mosquitoes are taking a pro active approach to these diseases. Currently laboratories are so backed up that it is often a month before results are obtained. With rapid test kits that are as accurate as the VScan rapid test kit, early diagnosis helps to control these diseases in an area. Early diagnosis and treatment can also reduce the severity of these diseases in the individual.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363
Web site: http://www.medicalservicesintl.com/